Table 3.
Network meta-analyses league table.
| BMT | CAS | CEA | |
|---|---|---|---|
| 30-day mortality | |||
| BMT | 99.9 (99.8%) | 0.12 (0.03, 0.46) | 0.18 (0.06, 0.54) |
| CAS | 8.41 (2.16, 32.71) | 7.7 (0.2%) | 1.55 (0.68, 3.54) |
| CEA | 5.42 (1.85, 15.95) | 0.65 (0.28, 1.47) | 42.4 (0.0%) |
| Long-term mortality | |||
| BMT | 20.1(5.8%) | 1.19 (0.54, 2.61) | 1.43 (0.89, 2.30) |
| CAS | 0.84 (0.38, 1.84) | 47.6 (27.6%) | 1.20 (0.65, 2.21) |
| CEA | 0.70 (0.43, 1.12) | 0.83 (0.45, 1.53) | 82.3 (66.6%) |
| 30-day ipsilateral stroke | |||
| BMT | 100 (100%) | 0.15 (0.06, 0.39) | 0.24 (0.12, 0.48) |
| CAS | 6.83 (2.60, 17.97) | 4.3 (0%) | 1.65 (0.81, 3.34) |
| CEA | 4.15 (2.09, 8.22) | 0.61 (0.30, 1.23) | 45.7 (0%) |
| Long-term ipsilateral stroke | |||
| BMT | 1.8 (0%) | 1.73 (0.95, 3.15) | 1.69 (1.41, 2.02) |
| CAS | 0.58 (0.32, 1.05) | 75.0 (53.6%) | 0.97 (0.55, 1.72) |
| CEA | 0.59 (0.50, 0.71) | 1.03 (0.58, 1.82) | 73.2 (46.4%) |
| 30-day myocardial infarction | |||
| BMT | 79.9 (60.7%) | 0.69 (0.05, 9.94) | 0.09 (0.01, 0.65) |
| CAS | 1.45 (0.10, 20.77) | 69.0 (39.3%) | 0.13 (0.02, 0.79) |
| CEA | 11.04 (1.53, 79.53) | 7.64 (1.27, 46.04) | 1.2 (0.0%) |
| 30-day ipsilateral minor stroke/TIA | |||
| BMT | 87.5 (76.4%) | 0.42 (0.19, 0.93) | 0.66 (0.21, 2.08) |
| CAS | 2.37 (1.07, 5.26) | 9.5 (22.3%) | 1.56 (0.62, 3.97) |
| CEA | 1.52 (0.48, 4.77) | 0.64 (0.25, 1.62) | 52.9 (1.3%) |
| Long-term ipsilateral minor stroke/TIA | |||
| BMT | 24.3 (0.2%) | 1.08 (0.04, 29.89) | 3.29 (1.45, 7.46) |
| CAS | 0.93 (0.03, 25.64) | 38.5 (48.1%) | 3.04 (0.01, 8.21) |
| CEA | 0.30 (0.13, 0.69) | 0.33 (0.01, 8.21) | 87.2 (51.7%) |
Estimates are presented as odds ratio (OR) with 95% confidence interval (CI) in parentheses. ORs above 1 suggest that the treatment listed in the upper row is superior; ORs below 1 suggest that the treatment listed in the left column is superior. Surface under the cumulative ranking curve values (SUCRAs) are given in the diagonal and the probability of being the best treatment in parentheses. Statistically significant values are given in bold. BMT, best medical therapy; CAS, carotid stenting; CEA, carotid endarterectomy; TIA, transient ischaemic attack.